Inari Medical

We’re excited to announce the launch of #VenaCore, the first mechanical #thrombectomy device designed to address the most challenging venous occlusions related to the long-term complications of #DVT. Featuring a laser-cut element with notched leading edges for the in-line treatment of venous occlusions, VenaCore is designed to engage, separate, and remove occlusions. Learn more by registering for our upcoming #ClotWarriorAcademy: https://bit.ly/4bFG12l

12 days until our next #ClotWarriorAcademy webinar! Designed specifically for #VTE Procedural Techs, this webinar will focus on collaborative strategies and best practices for physicians and techs. Register here: https://bit.ly/4e2NKYP

Join us at #TCT2024 for the late-breaking #PEERLESS RCT data release! PEERLESS is a randomized trial comparing the #FlowTriever System vs catheter-directed thrombolysis (CDT) for the treatment of intermediate-high risk #PE. #PulmonaryEmbolism #RandomizedTrial #LateBreakers #DataMatters Wissam A Jaber

Key predictors in #PE management: Ensuring the best decisions What are the key factors in selecting the optimal treatment for #PE? How can we guarantee that each eligible patient gets the appropriate care? Watch this short video as Dr Pablo Salinas and Dr Ana Viana Tejedor share their insights and experiences from Clinico San Carlos in Madrid, Spain. For a deeper dive, join our expert speakers for a practical discussion on new strategies for risk stratification, patient selection, and the latest scientific evidence in #PE management during #ESCCongress. 📅 When: 31 August at 15:15 📍 Where: Valletta Room or Channel 7 (online) Don't miss the #Inari Symposium - be part of the conversation shaping the future of PE management! #InterventionalCardiology #Cardiology #FlowTriever

US HCPs: LARGEST independent retrospective analysis of #FlowTriever at a major university medical center confirms safety and effectiveness for the treatment of high- and intermediate-risk PE patients. Key highlights: ✔ 286 PE patients from 2019 to 2023, including 8% with high-risk PE ✔ 6.8 mmHg average reduction in mPAP ✔ 49.3% of patients had no postprocedural ICU admission ✔ 0.7% pulmonary vascular injury ✔ #FlowSaver blood return system used in majority of cases since introduction in 2021 Read more: https://bit.ly/4dYqz1V #PulmonaryEmbolism #FlowTrieverSystem #DataMatters Travis McCain Pebror Indiana University School of Medicine

When it comes to treating #DVT, long-term patient outcomes matter. #CLOUT 2-year interim outcomes show sustained improvement in PTS symptoms at 2 years. More on CLOUT: https://bit.ly/3UWOO8O #safety #effectiveness #evidence

🌟Shaping the future of #PulmonaryEmbolism treatment with mechanical thrombectomy!🌟   Curious about how mechanical thrombectomy is advancing the treatment of #PE? Join our expert speakers for a practical discussion on new approaches to risk stratification, patient selection and the latest scientific evidence #PE management. And don't miss the announcement of groundbreaking new research!     When: 31st August Time: 15:15-16:00 📍 Where: Room Valletta or channel 7 (online)     We look forward to meeting you at the #Inari booth to answer any questions you have about the #FlowTriever system.   #InterventionalCardiology #Cardiology #ESCCongress

Drs. Daniel Fremed, MD FACS, Lorena DeMarco-Garcia, and Turna Mukherjee present two compelling cases of patients with challenging venous occlusions treated with #VenaCore. Read more: https://bit.ly/46NdqXh #InariMedical #MedicalInnovation #Healthcare More on VenaCore: https://bit.ly/45uvMLO

Congratulations to Dr. Sean Maratto and the team at Jefferson Health - Torresdale for successfully using the new #VenaCore #thrombectomy catheter to remove a challenging venous occlusion. Patient presented with swollen LLE and stent. The single-session treatment also involved #RevCore and T16 curve to clear the stent. More on VenaCore: https://bit.ly/45uvMLO

"Of all the advancements in PE #thrombectomy, the FlowSaver is the biggest." Drs. Ripal Gandhi, M.D., FSVM, FSIR and Andrew Niekamp discuss how the #FlowSaver Blood Return System allows interventionalists to focus on clinically meaningful endpoints and treat patients more effectively. Learn more about FlowSaver, celebrating use with 70k+ patients. #SIR #FlowTriever